On November 8, 2021 Instil Bio, Inc. ("Instil") (Nasdaq: TIL), a clinical-stage biopharmaceutical company focused on developing tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer, reported that company management will participate in two upcoming investor conferences in November (Press release, Instil Bio, NOV 8, 2021, View Source [SID1234594742]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Cowen 5th Annual IO Next Summit
Monday, November 15, 2021
Session Time: 4:45 PM – 5:05 PM ET
Live Session Link: View Source
Jefferies Global Healthcare Conference (London)
Thursday, November 18, 2021
Session Time: 3:00 AM ET
Session Link: View Source
An archived replay of the webcast will be available on the Company’s website for approximately 90 days following the presentation.
Both sessions can also be accessed by visiting the News & Events section of the Instil Bio website at www.instilbio.com.